On Dec. 9, the 2020 Face to Face Drug Plan Management Forum featured sessions on prior authorization, Canadian drug policy issues and impacts, plan design considerations related to chronic disease and pharmacy benefits management. Here’s what you missed! Biosimilars, pharmacogenetics shaping the future of pharmacy benefits management Plan sponsors with growing concerns about benefits plan […]